Independent risk factors for pressure ulcer development in a high-risk nursing home population receiving evidence-based pressure ulcer prevention: Results from a study in 26 nursing homes in BelgiumShow others and affiliations
2019 (English)In: International Wound Journal, ISSN 1742-4801, E-ISSN 1742-481X, Vol. 16, no 2, p. 325-333Article in journal (Refereed) Published
Abstract [en]
The aim of this study was to identify independent risk factors for pressure ulcer (PU) development in a high-risk nursing home population receiving evidence-based PU prevention. This study was part of a randomised controlled trial examining the (cost-)effectiveness of static air support surfaces compared with alternating pressure air mattresses. The sample consisted of 308 residents at a high risk of PU development (presence of non-blanchable erythema, Braden score ≤ 12 or Braden subscale "mobility" ≤ 2). PU incidence was monitored for 14 days. Demographic variables; functional, physical, and psychological characteristics; and data on skin assessment were collected. Independent risk factors were identified using multiple logistic regression analysis. The overall PU incidence (category II-IV) was 8.4% (n = 26), and 1.9% (n = 6) of the residents developed a deep PU (category III-IV). PUs (category II-IV) were significantly associated with non-blanchable erythema, a lower Braden score, and pressure area-related pain in high-risk residents even if preventive care was provided. These results highlight the need of a systematic risk assessment, including pain assessment and skin observations, in order to determine and tailor preventive care to the needs of high-risk individuals.
Place, publisher, year, edition, pages
Wiley-Blackwell Publishing Inc., 2019. Vol. 16, no 2, p. 325-333
Keywords [en]
High-risk population, nursing home, pressure ulcers, prevention, risk factors
National Category
Nursing Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
URN: urn:nbn:se:oru:diva-70119DOI: 10.1111/iwj.13032ISI: 000462632200003PubMedID: 30412652Scopus ID: 2-s2.0-85056321142OAI: oai:DiVA.org:oru-70119DiVA, id: diva2:1262569
Note
Funding Agency:
Frontier Medical Group, South Wales, United Kingdom
2018-11-122018-11-122019-06-19Bibliographically approved